Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated May 20, 2024
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Alnylam Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
May 16
| |||||||
Alnylam Pharmaceuticals, Inc.
|
0
|
$105.30 | -$2,762,570.94 |
—
|
0
|
Feb 29
|
Scheduled
| ||||||
Vir Biotechnology, Inc.
| 6.03K |
—
|
—
| +5.23% | 121.17K |
May 22
| |||||||
Alnylam Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
May 18
| |||||||
Alnylam Pharmaceuticals, Inc.
|
0
|
$132.13 | -$6,623,670.08 |
—
|
0
|
Aug 15
|
Scheduled
| ||||||
Syros Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 1
| |||||||
Vir Biotechnology, Inc.
| 6.41K |
—
|
—
| +5.89% | 115.15K |
May 23
| |||||||
Alnylam Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
May 18
| |||||||
Alnylam Pharmaceuticals, Inc.
|
0
|
$80.67 | -$4,160,100.00 |
—
|
0
|
Feb 9
|
Scheduled
| ||||||
Alnylam Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jul 15
| |||||||
Syros Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 8
| |||||||
Vir Biotechnology, Inc.
| 3.37K |
—
|
—
| +3.20% | 108.74K |
May 21
| |||||||
Alnylam Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
| 266.9K |
Dec 7
| |||||||
Alnylam Pharmaceuticals, Inc.
|
0
|
$67.10 | -$3,467,749.17 |
—
| 235.63K |
Nov 25
|
Scheduled
| ||||||
Vir Biotechnology, Inc.
|
0
|
—
|
—
|
—
|
0
|
May 21
| |||||||
Alnylam Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jul 1
| |||||||
Syros Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 11
| |||||||
Vir Biotechnology, Inc.
|
0
|
—
|
—
|
—
|
0
|
May 21
| |||||||
Alnylam Pharmaceuticals, Inc.
|
0
|
$71.24 | -$3,525,600.00 |
—
| 235.63K |
Feb 12
|
Scheduled
| ||||||
Alnylam Pharmaceuticals, Inc.
|
0
|
$54.07 | -$1,129,211.70 |
—
| 235.63K |
Nov 18
|
Scheduled
| ||||||
Vir Biotechnology, Inc.
| 222.22K |
—
|
—
| +1,348.42% | 238.7K |
Oct 16
| |||||||
Vir Biotechnology, Inc.
|
0
|
—
|
—
|
—
|
0
|
Oct 10
| |||||||
Vir Biotechnology, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Alnylam Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jul 1
| |||||||
Syros Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 11
| |||||||
Alnylam Pharmaceuticals, Inc.
|
0
|
$55.16 | -$992,092.00 |
—
| 235.63K |
Apr 15
|
Scheduled
| ||||||
Alnylam Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 20
| |||||||
Syros Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 14
| |||||||
Alnylam Pharmaceuticals, Inc.
|
0
|
$85.18 | -$1,914,750.00 |
—
| 140.79K |
Mar 13
|
Scheduled
| ||||||
Alnylam Pharmaceuticals, Inc.
|
0
|
$78.14 | -$1,525,800.00 |
—
| 140.79K |
Mar 9
|
Scheduled
| ||||||
Syros Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 8
| |||||||
Syros Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 8
| |||||||
Alnylam Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 2
| |||||||
Alnylam Pharmaceuticals, Inc.
|
0
|
$35.55 | -$212,874.76 |
—
| 140.79K |
Feb 1
|
Scheduled
| ||||||
Alnylam Pharmaceuticals, Inc.
|
0
|
$34.67 | -$98,400.00 |
—
| 140.79K |
Jan 25
|
Scheduled
| ||||||
Alnylam Pharmaceuticals, Inc.
|
0
|
$26.87 | -$328,806.00 |
—
| 140.79K |
Jan 18
|
Scheduled
| ||||||
Syros Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Sep 15
| |||||||
Syros Pharmaceuticals, Inc.
| 266.67K |
—
|
—
|
∞
| 266.67K |
Jul 6
| |||||||
Syros Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Alnylam Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 3
| |||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. | |||||||||||||
Want to view more results?
Unlock the hidden results with your Benzinga Account now. No purchase required.